Early Access — free while we kick the tires
EdgarHawk

Scheessele William John

Chief Commercial Officer

Officer
1 filing analyzed · 1 company · Latest 2025-04-15

Never miss a filing from Scheessele William John

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Humacyte, Inc. HUMA 1 0 Net buying

Activity

April 2025
2025-04-15 Humacyte, Inc. HUMA
high
Buy
6,493 shares
$9,999
Significance 8/10

CCO William Scheessele buys 6,493 HUMA shares at $1.54; stock down -83.7% from 52-week high amid sixth insider buy in 14 days.

Chief Commercial Officer William Scheessele purchased 6,493 shares at $1.54, increasing his holdings from 15,525 to 22,018 shares, during a period of severe equity depreciation: the stock trades -83.7% below its 52-week high of $9.46 and has fallen -49.3% in the past 30 days and -66.4% over 90 days. Critically, this purchase is part of a cluster pattern: 5 other insiders also bought within the past 14 days, indicating multi-executive accumulation at deeply depressed levels. The company is structurally challenged—posting $241,000 in latest-quarter revenue against a $-39,200,000 net loss for the full fiscal year—suggesting the insider buying may reflect views on intrinsic or recovery value rather than operational momentum. The cluster buy during sustained and severe drawdown warrants examination of whether insider knowledge about strategic direction, funding, or partnership development supports these simultaneous purchases at the bottom of the price decline.

Related insiders